Glenmark Pharmaceuticals Inc.Senior Microbiology Analyst Glenmark Pharmaceuticals Inc.Senior Microbiology AnalystMonroe, NCPreparation, review and approval of sampling matrix and hold time schedule Conducts and communicates results of lab investigations when test results fall outside pre-established specifications (OOS). Works collaboratively with other department stakeholders to ensure the services provided to the site are developed, tested, and delivered according to established procedures and regulations.
Glenmark Pharmaceuticals Inc.QC Microbiology Analyst I Glenmark Pharmaceuticals Inc.QC Microbiology Analyst IMonroe, NCAssists in the implementation of new changes at the site, Provide support to collect and prepare EMPQ reports, EM Trend reports, QMR board presentations with associated documentation. Works collaboratively with other department stakeholders to ensure the services provided to the site are developed, tested, and delivered according to established procedures and regulations.
Glenmark Pharmaceuticals Inc.Analytical Quality Assurance Specialist(Microbiology) Glenmark Pharmaceuticals Inc.Analytical Quality Assurance Specialist(Microbiology)Monroe, NCThe Analytical Quality Assurance (AQA) Specialist will work with the Quality Control team to work side by side on the floor acting as an in-process quality assurance expert for microbiology and chemistry laboratory activities to include all CGMP activities and testing of any materials, intermediate/finished product, and any utility/facility testing. Glenmark Pharmaceuticals Inc., USA is a subsidiary of Glenmark Pharmaceuticals Ltd., a leading player in the discovery of new molecules – both New Chemical Entities (NCE's) and New Biological Entities (NBEs'), with eight molecules in various stages of clinical development.
Glenmark Pharmaceuticals Inc.Microbiology Analyst Glenmark Pharmaceuticals Inc.Microbiology AnalystMonroe, NCPreparation, review and approval of sampling matrix and hold time schedule Conducts and communicates results of lab investigations when test results fall outside pre-established specifications and/or limits (OOS/OOL). Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with eight molecules in various stages of clinical development.